Equinox Gold (TSX:EQX) Announces Share Repurchase Program

VANCOUVER, British Columbia — February 26, 2026 — Leads & Copy — Equinox Gold Corp. has announced that the Toronto Stock Exchange (TSX) has accepted the company’s intention to launch a normal course issuer bid (NCIB) to repurchase shares. The company can repurchase up to 39,414,095 common shares, representing approximately 5% of the company’s issued and outstanding common shares as of February 18, 2026. The total number of shares outstanding is 788,281,919.

The purchases can be made at prevailing market prices between March 2, 2026, and March 1, 2027, or until the company reaches the maximum permitted purchases.

CEO Darren Hall stated that while Equinox Gold’s share price has increased significantly over the past nine months, the company believes the current price doesn’t adequately reflect its underlying value and long-term potential. He added that proceeds from asset divestments and cash flow from operating mines have allowed the company to reduce debt by over $1.1 billion since Q2 2025. This has strengthened the balance sheet and provided the financial flexibility to initiate a quarterly cash dividend of $0.015 per share, as announced on February 18th.

Hall said Equinox Gold is in a strong financial position and anticipates generating enough free cash flow in 2026 to support both the share repurchase and the dividend, bringing additional value to shareholders and underscoring the company’s commitment to strong shareholder returns.

Under the NCIB, purchases will be made through the facilities of the TSX, the NYSE American LLC, and/or alternative trading systems in Canada and the United States at prevailing market prices or other prices as permitted under the rules and policies of the TSX and the NYSE American, and applicable securities laws. All common shares purchased by the company will be canceled. Daily purchases on the TSX will be limited to a maximum of 660,178 common shares, representing 25% of the average daily trading volume of 2,640,714 shares for the six months ending January 31, 2026, subject to any purchases made under the block purchase exception.

Equinox Gold believes the NCIB is a flexible tool for its capital allocation program and that repurchasing shares at certain market prices is an appropriate use of company funds, benefiting both Equinox Gold and its shareholders. The company is not obligated to purchase any shares and may suspend or discontinue purchases at any time. The actual number of shares purchased and the timing of purchases will be determined by management based on market conditions, share price, cash availability, and other factors.

The company expects to enter an automatic share purchase plan (ASPP) related to NCIB purchases. The ASPP will facilitate repurchases during regulatory restriction or self-imposed blackout periods. Before any blackout period, the company may instruct its broker to purchase shares under the NCIB during the blackout period according to the ASPP terms. The broker will determine such purchases at its sole discretion based on purchasing parameters set by the company. The ASPP constitutes an “automatic securities purchase plan” under applicable securities laws and has been entered into according to TSX requirements. It will terminate when the NCIB expires, unless terminated earlier. All ASPP purchases will be included in the total number of shares purchased under the NCIB. Outside of blackout periods, shares may be purchased under the NCIB based on management’s discretion.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Equinox Gold is a Canadian mining company with gold operations in Canada and across the Americas, and a pipeline of development and expansion projects. The company is focused on disciplined execution, operational excellence and long-term value creation.

Source: Equinox Gold

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.